Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $202.93 | 6 | 91.9% |
| Gift | $18.00 | 1 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $119.44 | 1 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $28.77 | 2 | $0 (2017) |
| Chiesi USA, Inc. | $23.86 | 1 | $0 (2022) |
| ABIOMED | $20.37 | 1 | $0 (2024) |
| A-dec, Inc. | $18.00 | 1 | $0 (2020) |
| LeMaitre Vascular, Inc. | $10.49 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.37 | 1 | ABIOMED ($20.37) |
| 2022 | $23.86 | 1 | Chiesi USA, Inc. ($23.86) |
| 2020 | $18.00 | 1 | A-dec, Inc. ($18.00) |
| 2018 | $129.93 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($119.44) |
| 2017 | $28.77 | 2 | Takeda Pharmaceuticals America, Inc. ($28.77) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $20.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/13/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/04/2020 | A-dec, Inc. | — | Gift | In-kind items and services | $18.00 | General |
| 05/17/2018 | LeMaitre Vascular, Inc. | PROCOL (Device) | Food and Beverage | Cash or cash equivalent | $10.49 | General |
| Category: PROCOL | ||||||
| 02/28/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $119.44 | General |
| Category: Lower GI | ||||||
| 08/29/2017 | Takeda Pharmaceuticals America, Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Lower GI | ||||||
| 08/24/2017 | Takeda Pharmaceuticals America, Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Lower GI | ||||||
About Dr. Peter Lee, MD
Dr. Peter Lee, MD is a Cardiovascular Disease healthcare provider based in Peoria, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205886520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Lee, MD has received a total of $220.93 in payments from pharmaceutical and medical device companies, with $20.37 received in 2024. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($202.93).
Practice Information
- Specialty Cardiovascular Disease
- Location Peoria, AZ
- Active Since 05/10/2006
- Last Updated 07/02/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1205886520
Products in Payments
- Entyvio (Biological) $148.21
- CLEVIPREX (Drug) $23.86
- Impella (Device) $20.37
- PROCOL (Device) $10.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Peoria
Dr. Azimuddin Khawaja, Md, MD
Cardiovascular Disease — Payments: $327,140
Jesse Sethi, Md, MD
Cardiovascular Disease — Payments: $230,235
Dr. Sudhir Mungee, Md, MD
Cardiovascular Disease — Payments: $200,227
Rahul Sharma, Md, MD
Cardiovascular Disease — Payments: $184,798
Kishlay Anand, M.d, M.D
Cardiovascular Disease — Payments: $124,798
Dr. Mark Burns, M.d, M.D
Cardiovascular Disease — Payments: $121,824